Netflix exec loses job over ketamine confession

President Trump signed an executive order directing the FDA to review psychedelics designated as breakthrough therapy drugs for the treatment of PTSD and other mental health conditions. The move has garnered support from veterans and advocates, emphasizing potential new therapies.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل